ArticleOncotarget2018

MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models.

Francesca Vena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.